Ontario Centre of Forensic Sciences

Novel Biotechnology Inc. Secures $2.5 Million in Seed Round Funding

Retrieved on: 
Wednesday, September 27, 2023
Biotechnology, General Health, Other Health, Health, Pharmaceutical, DNA, Plasmid, Ministry of Economic Development, Job Creation and Trade, Novel, Ontario Center, New York, Multimedia, Research, Government, NBX, Economic development, CFO, Growth, Ontario Centre of Forensic Sciences, OCI, D, Pharmaceutical industry, Fine chemical, Vaccine

Novel Biotechnology Inc., an innovative biotechnology start-up headquartered in Canada, is pleased to announce the successful completion of its $2.5 million seed round funding.

Key Points: 
  • Novel Biotechnology Inc., an innovative biotechnology start-up headquartered in Canada, is pleased to announce the successful completion of its $2.5 million seed round funding.
  • Co-founded by CEO Pankaj Khanna and a team of accomplished serial entrepreneurs, Novel Biotechnology is on a mission to revolutionize the plasmid DNA market.
  • The proceeds from the seed round will be utilized to expand Novel's existing plasmid services business and expedite its platform R&D initiatives.
  • Congratulations, Novel Biotechnology.”
    "Due to the strong growth within the pDNA market, Novel expects robust revenue growth and profitability by FY2025," said Konstantin Rodionov, CFO & Co-Founder of Novel Biotechnology.

PharmAla Receives First Office Action for PharmAla-1 PCT Filing

Retrieved on: 
Monday, September 25, 2023
BIO, Intellectual property, Ontario Centre of Forensic Sciences, Partnership, CSE, University, P-1, Prior art, Medicine, University of Arkansas for Medical Sciences, Medication, MDXX, Innovation, Research, Patent Cooperation Treaty, PCT, CNS, Central nervous system, OTC, Toxicology, MDMA, Pharmacology, Safety, Pharmaceutical industry

VANCOUVER, British Columbia, Sept. 25, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including MDMA), is proud to announce that it has received the first office action from the Patent Cooperation Treaty (PCT) filing for the company’s novel PharmAla-1 (P-1) molecule.

Key Points: 
  • VANCOUVER, British Columbia, Sept. 25, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including MDMA), is proud to announce that it has received the first office action from the Patent Cooperation Treaty (PCT) filing for the company’s novel PharmAla-1 (P-1) molecule.
  • “The generation of novel intellectual property is incredibly important for drug discovery companies like PharmAla.
  • This First Office Action for P-1 shows that our drug discovery pipeline yields novel, inventive molecules with significant value as neuropsychiatric therapeutics,” said Nick Kadysh, CEO, PharmAla Biotech.
  • “Our development pipeline, which can yield new molecules appropriate for pre-clinical development, is an incredible asset for PharmAla.

PharmAla Files Patent for Novel MDXX Molecule PharmAla-1

Retrieved on: 
Monday, July 31, 2023
ABA, University, Autumn, Ontario Centre of Forensic Sciences, Partnership, CSE, Spectrum, Autism spectrum, Medicine, University of Arkansas for Medical Sciences, MDXX, Hope, Innovation, Research, Composition of matter, IP, Computational chemistry, CNS, Drug design, Central nervous system, MDMA, Patent, ASD, NCE, ALA, Psychedelic drug, OTC, Drug discovery, Psychiatry, Social anxiety, Safety, Pharmaceutical industry, Pharmacology

PharmAla’s novel drug development pipeline has been advancing rapidly in 2023, with PharmAla’s ALA family moving rapidly into clinical development.

Key Points: 
  • PharmAla’s novel drug development pipeline has been advancing rapidly in 2023, with PharmAla’s ALA family moving rapidly into clinical development.
  • The Composition of Matter patent on the Novel Chemical Entity (NCE) PharmAla-1 will further strengthen the company’s position as a leading developer of Central Nervous System (CNS) pharmaceutical treatments.
  • PharmAla-1 is the first molecule of PharmAla’s extensive computational drug development pipeline, which PharmAla is announcing to the market in detail; PharmAla’s ALA and ABA patent families were developed via traditional drug discovery.
  • PharmAla is also excited to announce the acceptance of its review article titled "Balancing therapeutic efficacy and safety of MDMA and novel MDXX analogues as novel treatments for autism spectrum disorder" for publication in Psychedelic Medicine.

TROES Receives Funding Support for $1.5 million Groundbreaking Mobile Portable EV Charging Solution

Retrieved on: 
Friday, June 16, 2023
Other Energy, Automotive, EV, Electric Vehicles, Manufacturing, Alternative Energy, Energy, Other Manufacturing, NECA, Partnership, DNS, Ministry of Economic Development, Job Creation and Trade, Ministry, DCFC, Economic development, Ontario Centre of Forensic Sciences, Commercial, OCI, BESS, Renewable energy, Innovation

This groundbreaking project is the first of its kind and combines innovative features such as a portable EV charger, foldable solar panels, smart energy storage, and microgrid control.

Key Points: 
  • This groundbreaking project is the first of its kind and combines innovative features such as a portable EV charger, foldable solar panels, smart energy storage, and microgrid control.
  • This unique combination of cutting-edge technologies is set to revolutionize the deployment of EV charger solutions.
  • The product is well-suited to non-urban environments, enabling EV charging capability without the need for permanent infrastructure.
  • "We are excited to partner with TROES Corp on this ground-breaking project," said Bob Eaton, Managing Member of Day & Night Solar.

PharmAla Awarded Research Grant by Ontario Centre for Innovation

Retrieved on: 
Friday, June 9, 2023
US Foods, CSE, University, Therapy, Drug discovery, UAMS, USFDA, MDXX, Innovation, Medicine, Psychedelic drug, Patient, Clinical research, OTC, Ontario Centre of Forensic Sciences, OCI, Conference, MDMA, Food, Pharmaceutical industry, Research

TORONTO, June 09, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA)(OTC:PMBHF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including MDMA), is excited to announce that it has been granted a research grant by the Ontario Centre for Innovation in conjunction with the University of Windsor.

Key Points: 
  • TORONTO, June 09, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA)(OTC:PMBHF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including MDMA), is excited to announce that it has been granted a research grant by the Ontario Centre for Innovation in conjunction with the University of Windsor.
  • PharmAla believes that this can be done through the aid of in-silico modelling.
  • To do that, our research team encompasses a diverse group of scientists: Preclinical researchers completing animal model research, In-Silico Drug Discovery, and very soon, Clinical Research,” said Nick Kadysh, CEO, PharmAla Biotech.
  • “The OCI grant will allow us to bolster the funnel of our drug pipeline and develop valuable IP with non-dilutive funding.

Invest WindsorEssex partners with Virtualware to accelerate VR CAVE capabilities for the automobility sector

Retrieved on: 
Thursday, April 27, 2023
WE, IWE, Partnership, 3D, SME, Innovation, 2D, VR, EPA, Virtual reality, Ontario Centre of Forensic Sciences, Ecosystem, OCI, Agency for Strategic Initiatives (Russia), Torgeir Vraa, Video game

Today’s announced partnership between Invest WindsorEssex and Virtualware further supports innovation in Canada’s automobility ecosystem through the expansion of IWE’s VR CAVE capabilities and the programming available to companies through the WE RTDS.

Key Points: 
  • Today’s announced partnership between Invest WindsorEssex and Virtualware further supports innovation in Canada’s automobility ecosystem through the expansion of IWE’s VR CAVE capabilities and the programming available to companies through the WE RTDS.
  • The IWE VR CAVE will now include a unique integration with VIROO, the pioneering VR as a Service (VRaaS) platform developed by Virtualware.
  • The three-year partnership between IWE and Virtualware will leverage each organization’s strengths and accelerate the adoption of VR in Ontario-based SMEs.
  • “Our partnership with Invest WindsorEssex, Canada’s mobility innovative cluster, will accelerate VR adoption across the automotive industry, creating valuable opportunities and building the most powerful enterprise VR ecosystem in the country," Unai Extremo, CEO, Virtualware.

Nissan and Acerta unveil failure prediction analytics, developed with support from Government of Ontario through OVIN

Retrieved on: 
Wednesday, March 8, 2023
OCI, Ontario Centre of Forensic Sciences, Turbine engine failure, Ecosystem, Ministry of Economic Development, Job Creation and Trade, Research, Travel, Electric City, Government, Machine learning, International, Failure, Partnership, British Rail Research Division, Economic development, Anomaly, Artificial intelligence, Transport, CAD, AI, Automotive industry, Nissan

KITCHENER, Ontario, March 8, 2023 /PRNewswire-PRWeb/ -- Acerta Analytics – provider of manufacturing technology and Industry 4.0 solutions for the automotive industry – is pleased to announce the completion of a specialized platform of predictive machine learning models developed with Nissan, Japan. The project was funded in part through the Ontario Vehicle Innovation Network (OVIN) led by the Ontario Centre of Innovation (OCI).

Key Points: 
  • Acerta Analytics announces the completion of a specialized platform of predictive machine learning models developed with Nissan, Japan.
  • The project was funded in part through the Ontario Vehicle Innovation Network (OVIN) led by the Ontario Centre of Innovation (OCI).
  • Acerta's custom analytics solution detects subtle anomalies in vehicle data to predict a potential failure within an engine component.
  • Watch this Nissan and Acerta Failure Prediction Analytics Demonstration Day video to see some highlights from the event.

OVIN and FBCL announce strategic partnership to improve Cross-Border Transportation Technologies

Retrieved on: 
Tuesday, January 10, 2023
Silver Lake State Park (Michigan), Transport, MOU, Economic development, Federal Bridge Corporation, Government, Travel, Ontario Centre of Forensic Sciences, Partnership, Organization, OCI, Ministry of Economic Development, Job Creation and Trade, Growth, Movement, Drug, Renewable energy

TORONTO, Jan. 10, 2023 (GLOBE NEWSWIRE) -- To respond to the evolving needs of Ontario’s automotive and mobility ecosystem the Ontario Vehicle Innovation Network (OVIN), through the Ontario Centre of Innovation (OCI) and The Federal Bridge Corporation Limited (FBCL) will work closely to identify synergies to improve the movement of people and goods across borders. This collaboration will also address the need to identify, pilot, and adopt new technologies and solutions across the sectors.

Key Points: 
  • This collaboration will also address the need to identify, pilot, and adopt new technologies and solutions across the sectors.
  • OVIN, through OCI and the FBCL have signed a Memorandum of Understanding (MOU) to strengthen their collaboration.
  • The MOU will explore opportunities to help people and goods move safely and efficiently across the border by leveraging innovative automotive and mobility technologies.
  • “FBCL is pleased to partner with OVIN to establish this relationship that will fuel the next generation of mobility and goods movement across our border,” said Ms. Natalie Kinloch, CEO of the FBCL.

Microgreen Energy and MTB to Integrate Transit Bus EV Battery System

Retrieved on: 
Tuesday, December 20, 2022
Government, Ministry of Economic Development, Job Creation and Trade, EV, Organization, Ontario Centre of Forensic Sciences, Travel, Transport, Government of Ontario, MTB, OCI, Economic development, Rail transport

With funding from the Government of Ontario through OVIN, the project aims to extend Ontario's EV supply chain to include bus-scale battery packs

Key Points: 
  • The objective of this joint project is to extend Microgreen's lithium battery integration expertise into the growing electric transit bus segment, and to leverage MTB's scale and experience in refurbishing diesel transit buses to establish a cost-effective alternative platform that combines an extended-life chassis with a latest technology clean-energy propulsion system.
  • "Our government is proud to support collaborations between businesses like Microgreen Energy and MTB Transit Solutions, who are developing clean energy options for electric transit buses," said Vic Fedeli, Minister of Economic Development, Job Creation and Trade.
  • "This innovative joint project will have a positive impact on the growing electric transit bus sector, while also ensuring Ontario remains a global leader in the auto and EV sector."
  • "Our government understands that transit bus electrification is no longer just a pilot-scale undertaking," said Caroline Mulroney, Minister of Transportation and Francophone Affairs.

New Collaboration Between Extract Energy and Hamilton Community Enterprises Will Harvest “Free” Energy

Retrieved on: 
Wednesday, November 9, 2022
GLOBE, HCE, Carbon, Sustainable Development Technology Canada, City, Ontario Centre of Forensic Sciences, Alloy, Temperature, GTHA, Ministry of Environment, Energy and Telecommunications, Technology, Heat engine, Energy, Electricity, Heart, CEO, Telecommunication, Renewable energy, MaRS Discovery District

CAMBRIDGE, Ontario, Nov. 09, 2022 (GLOBE NEWSWIRE) -- This week, Extract Energy launched a pilot project with Hamilton Community Enterprises (HCE) to demonstrate new technology designed to harvest a vast, untapped source of clean electricity.

Key Points: 
  • CAMBRIDGE, Ontario, Nov. 09, 2022 (GLOBE NEWSWIRE) -- This week, Extract Energy launched a pilot project with Hamilton Community Enterprises (HCE) to demonstrate new technology designed to harvest a vast, untapped source of clean electricity.
  • Extract Energys Heat Engine will capture excess hydrothermal energy from a City of Hamilton district heating and cooling plant and convert it into grid-quality electricity.
  • Hamilton Community Enterprises (HCE) provides facilities-based integrated utility solutions across both the Energy and Telecommunication sectors since the deregulation of Ontarios electricity market in 2000.
  • Wholly owned by the City of Hamilton, HCE focuses on providing transformative community-based network solutions across the Greater Toronto Hamilton Area.